Report
Pharmaceuticals, Biotechnology: New COVID variant sends vaccines stocks up, though a lot remains unknown
Pharmaceuticals, BiotechnologyNew COVID variant sends vaccines stocks up, though a lot remains unknown
New variant raises worries and boosts shares of vaccine developers
Concerns around a large number of mutations
Vaccines makers are getting ready for the worst-case scenario
Provider
Bryan Garnier
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Olga Smolentseva
Other Reports from Bryan Garnier
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.